Home > Boards > US Listed > Biotechs > Sorrento Therapeutics, Inc. (SRNE)

Qsachse , EXCELLENT find ! ..... Thank you

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
purefreewater Member Profile
 
Followed By 58
Posts 3,490
Boards Moderated 0
Alias Born 09/27/09
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 10/29/2020 9:01:33 AM
Sorrento Announces That Intranasal Administration of COVI-AMG™ Neutralizing Antibody Prevented COVID-19 Disease Progression... GlobeNewswire Inc. - 10/29/2020 9:00:10 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 10/22/2020 5:26:19 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 10/22/2020 5:26:12 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/21/2020 4:17:18 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/21/2020 6:05:40 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/20/2020 5:22:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/20/2020 9:01:07 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/16/2020 4:31:25 PM
Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Therapeutics’ Large Phase 2 Clinical Trial of Abivertinib i... GlobeNewswire Inc. - 10/14/2020 11:56:46 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/13/2020 6:04:05 AM
Sorrento Adds Mesenchymal Stem Cell Program (MSC) That Has Been Cleared for a Phase 1 Trial by the FDA to the Pipeline of COV... GlobeNewswire Inc. - 10/12/2020 5:20:59 PM
Sorrento COVID-19 R&D October 13, 2020 Pipeline Call Details Released GlobeNewswire Inc. - 10/9/2020 7:46:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2020 1:09:05 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/8/2020 5:23:03 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 10/8/2020 4:16:35 PM
Sorrento Announces the Discovery of Salicyn-30 Small Molecule That Strongly Inhibits SARS-CoV-2 Infection in Preclinical Stud... GlobeNewswire Inc. - 10/7/2020 3:09:42 PM
Scilex Holding Company, a Subsidiary of Sorrento Therapeutics, Announces Continuous Sales Growth in ZTlido® and Expects to C... GlobeNewswire Inc. - 10/7/2020 6:00:10 AM
Sorrento to Host a R&D Day to Showcase COVID-19 Product Pipeline GlobeNewswire Inc. - 10/4/2020 6:39:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/2/2020 4:16:45 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/30/2020 5:22:59 PM
SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST... GlobeNewswire Inc. - 9/30/2020 9:26:45 AM
Sorrento Therapeutics and ViralClear Enter Into Agreement to Explore Combination Antibody Plus Antiviral Therapy Against COVI... GlobeNewswire Inc. - 9/30/2020 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2020 6:08:09 AM
Sorrento Releases Preclinical Data for STI-1499 (COVI-Guard™) and STI-2020 (COVI-AMG™), Potent Neutralizing Antibodies Ag... GlobeNewswire Inc. - 9/28/2020 11:59:34 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences